Literature DB >> 14506638

P16 overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix.

Nobuo Masumoto1, Takuma Fujii, Mitsuya Ishikawa, Miyuki Saito, Takashi Iwata, Takeshi Fukuchi, Nobuyuki Susumu, Makio Mukai, Kaneyuki Kubushiro, Katsumi Tsukazaki, Shiro Nozawa.   

Abstract

Carcinogenesis of cervical cancer has been investigated, and p16(INK4a) overexpression in squamous cell carcinoma of the cervix has been reported as a result of infection by human papillomavirus (HPV) (eg, HPV 16), and the consequence of the retinoblastoma (Rb) protein inactivation by HPV E7 protein. However, to our knowledge, there have been no studies on the relation between p16(INK4a) overexpression associated with HPV and small cell carcinoma of the cervix, which behaves more aggressively clinically than squamous cell carcinoma. The purpose of this study was to determine whether p16(INK4a) is overexpressed in small cell carcinoma, and if p16(INK4a) is overexpressed, the types of HPV that are related to this cancer. We reviewed 10 cases of small cell carcinoma and examined them for p16(INK4a) overexpression by immunohistochemistry. We also performed HPV typing with polymerase chain reaction (PCR)-sequencing analysis and in situ hybridization and found that p16(INK4a) was overexpressed in every case. PCR-sequencing analyses revealed that all cases were HPV-positive and that 9 cases were positive for HPV 18. Five of the 9 cases positive for HPV 18 were also positive by in situ hybridization and yielded a punctate signal, considered to represent the integrated form. In conclusion, p16(INK4a) was overexpressed and HPV 18 was frequently detected in an integrated form in small cell carcinoma. Therefore, inactivation of Rb protein by HPV 18 E7 protein may be associated with carcinogenesis of small cell carcinoma the same as inactivation of Rb protein by HPV 16 E7 protein is associated with carcinogenesis of squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14506638     DOI: 10.1016/s0046-8177(03)00284-3

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  23 in total

1.  Cadherins, catenins and cell cycle regulators: impact on survival in a Gynecologic Oncology Group phase II endometrial cancer trial.

Authors:  Meenakshi Singh; Kathleen M Darcy; William E Brady; Rashna Clubwala; Zachary Weber; Jon V Rittenbach; Ali Akalin; Charles W Whitney; Richard Zaino; Nilsa C Ramirez; Kimberly K Leslie
Journal:  Gynecol Oncol       Date:  2011-08-03       Impact factor: 5.482

2.  Expression of E6, p53 and p21 proteins and physical state of HPV16 in cervical cytologies with and without low grade lesions.

Authors:  Diana K Jiménez Tagle; Daniel Hernández Sotelo; Berenice Illades-Aguiar; Marco A Leyva-Vazquez; Eugenia Flores Alfaro; Yaneth Castro Coronel; Oscar Del Moral Hernández; Luz Del Carmen Alarcón Romero
Journal:  Int J Clin Exp Med       Date:  2014-01-15

3.  Mixed Mesonephric Adenocarcinoma and High-grade Neuroendocrine Carcinoma of the Uterine Cervix: Case Description of a Previously Unreported Entity With Insights Into Its Molecular Pathogenesis.

Authors:  Marcela S Cavalcanti; Anne M Schultheis; Caleb Ho; Lu Wang; Deborah F DeLair; Britta Weigelt; Ginger Gardner; Stuart M Lichtman; Meera Hameed; Kay J Park
Journal:  Int J Gynecol Pathol       Date:  2017-01       Impact factor: 2.762

4.  Next-generation Sequencing Reveals Recurrent Somatic Mutations in Small Cell Neuroendocrine Carcinoma of the Uterine Cervix.

Authors:  Deyin Xing; Gang Zheng; John Kenneth Schoolmeester; Zaibo Li; Aparna Pallavajjala; Lisa Haley; Michael G Conner; Russell Vang; Chien-Fu Hung; Tzyy-Choou Wu; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2018-06       Impact factor: 6.394

5.  [Neuroendocrine carcinomas of the cervix].

Authors:  D Schmidt; L-C Horn; F Kommoss
Journal:  Pathologe       Date:  2005-07       Impact factor: 1.011

6.  Tissue transglutaminase 2 as a biomarker of cervical intraepithelial neoplasia (CIN) and its relationship to p16INK4A and nuclear factor kappaB expression.

Authors:  Ruchi Gupta; Radhika Srinivasan; Raje Nijhawan; Vanita Suri
Journal:  Virchows Arch       Date:  2009-11-25       Impact factor: 4.064

7.  Prognostic factors and treatment comparison in early-stage small cell carcinoma of the uterine cervix.

Authors:  W J Tian; M Q Zhang; R H Shui
Journal:  Oncol Lett       Date:  2011-10-12       Impact factor: 2.967

Review 8.  p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis.

Authors:  I Tsoumpou; M Arbyn; M Kyrgiou; N Wentzensen; G Koliopoulos; P Martin-Hirsch; V Malamou-Mitsi; E Paraskevaidis
Journal:  Cancer Treat Rev       Date:  2009-03-03       Impact factor: 12.111

9.  Ancillary testing of liquid-based cytology specimens for identification of patients at high risk of cervical cancer.

Authors:  Takuma Fujii; Miyuki Saito; Takashi Iwata; Nobumaru Hirao; Hiroshi Nishio; Akiko Ohno; Katsumi Tsukazaki; Makio Mukai; Kaori Kameyama; Daisuke Aoki
Journal:  Virchows Arch       Date:  2008-10-21       Impact factor: 4.064

Review 10.  Virus-Driven Carcinogenesis.

Authors:  Yuichiro Hatano; Takayasu Ideta; Akihiro Hirata; Kayoko Hatano; Hiroyuki Tomita; Hideshi Okada; Masahito Shimizu; Takuji Tanaka; Akira Hara
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.